Skip to main content

Table 1 Examples of studies examining the prognostic relevance of disseminated tumor cells identified by immunocytochemistry in bone marrow of breast cancer patients without overt distant metastases (stage M0)

From: Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance

Study (year) [reference]

Detection rate (percent)

Prognostic value (no. of patients)

Schlimok et al. (1987) [103]

18

DDFS (155)

Cote et al. (1991) [81]

37

DFS, OS (49)

Harbeck et al. [104]

38

DFS, OSa (100)

Diel et al. (1996) [82]

31

DFSa, OSa (727)

Molino et al. (1997) [105]

31

None (109)

Mansi et al. (1999) [83]

25

DFS, OS (350)

Braun et al. (2000) [10]

36

DFSa, OSa (552)

Gebauer et al. (2001) [4]

42

DFSa, OSa (393)

Gerber et al. (2001) [6]

31

DFSa, OSa (484)

Wiedswang et al. (2003) [22]

13

DDFSa, BCSSa (817)

Braun et al.: pooled analysis (2005) [8]

31

DDFSa, OSa (4,703)

  1. aConfirmed by multivariate analysis. BCSS, breast cancer-specific survival; DDFS, distant-DFS; DFS, disease-free survival; OS, overall survival.